First-Ever trial tests if removing lymph nodes helps control rare kidney cancer
NCT ID NCT06262516
Summary
This study aims to find out if removing lymph nodes during surgery for a rare type of kidney and urinary tract cancer helps prevent the cancer from coming back. Researchers will compare two groups of patients: one that has the standard surgery and another that has the standard surgery plus lymph node removal. The main goal is to see which approach leads to better long-term control of the disease over two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic Glickman Urological and Kidney Institute
RECRUITINGCleveland, Ohio, 44195, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Southern Illinois University
RECRUITINGSpringfield, Illinois, 62702, United States
Contact Email: •••••@•••••
Contact
-
University Hospitals Cleveland Medical Center, Urology Institute, Case Comprehensive Cancer Center
RECRUITINGCleveland, Ohio, 44106, United States
Contact Email: •••••@•••••
Contact
-
University of Florida Health Science Center
RECRUITINGGainesville, Florida, 32209, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.